Find your next paid study

BioNTech SENCT07798648

Human Papillomavirus (HPV) Vaccines

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Human papillomavirus (HPV) vaccines have potential to prevent an average of 26,900 cancer cases each year in the United States, but vaccine coverage rates rema…

University of FloridaNCT03429413

Phase 4

Novel Serotype Alert: Investigate New Pneumococcal Conjugate Vaccines for Inducing Cross-protection Against Newly Discovered Serotype 33E and Putative Novel Serogroup 33 Serotypes

The goal of this study is to learn whether different types of vaccines to prevent bacterial infections are able to effectively create antibodies that defend ag…

VaccinePneumococcal Disease

University of Alabama at BirminghamNCT07135453

Human Papillomavirus Ends Here: A Multilevel Intervention to Increase Uptake of the HPV Vaccine Among Adolescents

Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the …

HPV Vaccine

University of California, DavisNCT06831929

Phase 4

A PHASE 4, RANDOMIZED, DOUBLE-BLIND, THIRD-PARTY-UNBLINDED STUDY TO INVESTIGATE THE SAFETY AND TOLERABILITY OF A BNT162B2 RNA-BASED, VARIANT-ADAPTED VACCINE CANDIDATE AGAINST SARS-COV-2 AND EVALUATE THE CIRCULATING SARS-COV-2 SPIKE PROTEIN LEVEL IN HEALTHY PARTICIPANTS 18 THROUGH 64 YEARS OF AGE

The purpose of this study is to learn about the safety and effects of an updated COVID-19 vaccine (called BNT162b2) in adults 18 to 64 years of age. This stud…

COVID-19 Vaccines

MeaslesMumpsRubella+2 more

BioNTech SENCT07730450

Phase 3

A Phase 3a, Observer-blind, Randomized, Controlled Study to Demonstrate Lot-to-lot Consistency and Evaluate the Immunogenicity and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine Compared With ProQuad, Administered as a Second Dose in Healthy Children 4-6 Years of Age

The purpose of this study is to evaluate how consistently 3 different manufacturing lots of the GSK's investigational measles, mumps, rubella, and varicella (M…

GlaxoSmithKlineNCT07742644

Vaccine HesitancyVaccine Refusal

Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support

The goal of this project is to establish the technical feasibility of a scalable, integrated platform to improve patient informed decision-making and increase …

Johns Hopkins Bloomberg School of Public HealthNCT06482450

~$10 – $5,625

Phase 4

Systems Biological Assessment of the Durability of Vaccine Responses

The ability of the vaccines today to generate a long-lasting protection against infections varies greatly from one vaccine to another. The yellow fever vaccine…

Vaccine Response

Emory UniversityNCT05801978

Phase 1

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

The goal of this research is to learn more about ZADAXIN® (trade name; thymalfasin generic; Ta1 for short) and determine if Ta1 has any benefit in increasing t…

Vaccine ResponseCOVID-19 VaccineImmune Response to Covid 19 Vaccination

The Methodist Hospital Research InstituteNCT06821100

Phase 3

A Phase 3a, Observer Blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of Intramuscular Administration of an Investigational Combined Measles, Mumps, Rubella, and Varicella Vaccine Compared With Intramuscular Administration of ProQuad When Administered as a Second Dose to Healthy Children Aged 15 Months to 6 Years of Age

This study is evaluating the immunogenicity and safety of intramuscular administration of the investigational MMRVNS vaccine compared to intramuscular administ…

MeaslesMeasles-Mumps-Rubella+Chickenpox Vaccine

GlaxoSmithKlineNCT07406360

HPVVaccine-Preventable Diseases

A Pilot Randomized Controlled Study to Examine Feasibility and Preliminary Effectiveness of a Game-based Intervention in Promoting HPV Vaccination Among Vulnerable Youth to Prevent Cancers

This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake…

Michigan State UniversityNCT05984849

Human Papilloma Virus Vaccine

The STOP-HPV Scale Up Study

Human papillomavirus (HPV) causes 35,900 US cancer cases per year, 4,000 deaths, and $4 billion in can In this study, the investigators will conduct a 3-arm cl…